A treatment planning study evaluating a ‘simultaneous integrated boost’ technique for accelerated radiotherapy of stage III non-small cell lung cancer

This publication has 37 references indexed in Scilit:

• O-125 ECOG 2597: Phase III study of induction chemotherapy followed by standard thoracic radiotherapy (STD TRT) vs hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage III A & B non-small cell lung cancer
  Lung Cancer, 2003
• An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer
  Lung Cancer, 2001
• Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study
  European Journal Of Cancer, 2000
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999
• Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
  Lung Cancer, 1999
• Image Registration: An Essential Part of Radiation Therapy Treatment Planning
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Fraction Size and Dose Parameters Related to the Incidence of Pericardial Effusions
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the radiation therapy oncology group (RTOG 83-12): long-term results
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients
  International Journal of Radiation Oncology*Biology*Physics, 1991